CD163 and cutaneous melanoma: As high cytotoxic T lymphocyte (CTL)/regulatory T cell (Treg) and high M1 (CD68+CD163-)/M2 macrophage ratios have been found to be associated with improved survival in breast cancer and cutaneous melanoma, respectively [14, 18], we evaluated these ratios in our study.